EYLEA® (aflibercept) Injection
Search documents
Regeneron Pharmaceuticals (NasdaqGS:REGN) FY Earnings Call Presentation
2026-01-12 22:15
J.P. Morgan Healthcare Conference J a n u a r y 1 2 , 2 0 2 6 This non-promotional presentation contains investigational data as well as forward-looking statements; actual results may vary materially. J.P. Morgan Healthcare Conference Dr. Leonard Schleifer, MD, PhD Board Co-Chair, Co-Founder, President, & Chief Executive Officer Dr. George Yancopoulos, MD, PhD Board Co-Chair, Co-Founder, President, & Chief Scientific Officer 2 Note regarding forward-looking statements and non-GAAP financial measures This pr ...